首页> 外文期刊>Journal of cardiothoracic and vascular anesthesia >New frontiers in aortic therapy: Focus on deliberate hypotension during thoracic aortic endovascular interventions
【24h】

New frontiers in aortic therapy: Focus on deliberate hypotension during thoracic aortic endovascular interventions

机译:主动脉治疗的新领域:专注于胸主动脉腔内介入治疗期间的故意低血压

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

THORACIC AORTIC ENDOVASCULAR interventions have blossomed in recent years and have progressed around the aortic arch all the way to replacement of the aortic valve. The entire thoracic aorta is now amenable to endovas-cular repair in selected patients. These transcatheter procedures frequently require brief deliberate hypotension to facilitate precise hardware deployment. The described techniques for deliberate hypotension in these settings include nitrovasodila-tors, adenosine, balloon vena cava occlusion and rapid ventricular pacing. Rapid ventricular pacing has evolved to become the current gold standard in the contemporary era due to its efficacy, predictability, consistency, rapid reversibility, and potential to assist in hemodynamic recovery after endovascular device deployment. Further clinical trials will likely explore alternatives in the setting of this current clinical paradigm.
机译:近年来,胸主动脉瓣膜介入治疗日益普及,并一直在主动脉弓周围发展,一直到更换主动脉瓣。现在,整个胸主动脉适合于某些患者的血管内修复。这些经导管手术通常需要短暂的故意低血压以促进精确的硬件部署。所描述的在这些情况下故意降低血压的技术包括硝基血管扩张剂,腺苷,球囊腔静脉闭塞和快速心室起搏。快速心室起搏由于其功效,可预测性,一致性,快速可逆性以及在部署血管内装置后有助于血液动力学恢复的潜力,已发展成为当今时代的当前金标准。进一步的临床试验可能会探索这种当前临床范例的替代方案。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号